Drugs / Tartarase
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT06139835 | Jun → Jul 2022 | — | Pontis Biologics, Inc. | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Tartarase | “Pontis Biologics, Inc. has developed novel model of calculus development and structure and has formulated a dentifrice (Tartarase™) using digestive enzymes as active...” PMID 38909189 ↗ Jun 2024 |
| Modality | Protein / enzyme biologic | “has formulated a dentifrice (Tartarase™) using digestive enzymes as active ingredients” PMID 38909189 ↗ Jun 2024 |
| Route | Topical | “filled a dental tray with Tartarase and covered the 6 lower front teeth” NCT06139835 ↗ |